The consumables product type segment held a major revenue share of 62.87% in 2022. These advancements have given rise to a surge in demand for cell separation processes, thus propelling market growth to new heights. The landscape has been further transformed by increased investments and government funding, fostering the availability of advanced techniques for cell isolation and biopharmaceutical production. Their work shed light on the immune responses of COVID-19-infected patients, employing blood samples from both patients and healthy individuals. A striking example is the utilization of cutting-edge immunoprecipitation identified by flow cytometry (IP-FCM) tests by researchers at Seattle Children's Research Institute in 2020. The impact of the pandemic has also fueled market growth. The rise in funding from governmental bodies for cell-based research further underscores its potential in managing chronic ailments like cancer, contributing to the upward trajectory of the global market.
Industry leaders are strategically focused on advancing and commercializing innovative products to meet the needs of researchers and healthcare professionals, thereby stimulating the demand for cell isolation solutions in the coming years.Ĭellular therapies are gaining momentum for treating various significant diseases, including neurological disorders like Parkinson's disease and spinal cord injuries, as well as autoimmune conditions such as multiple sclerosis and Crohn's disease.
#Stem cell reports impact factor driver
The global cell separation market is poised for remarkable growth, with an anticipated size of USD 9.05 billion by 2030 and a robust CAGR of 9.82%.Ī surge in demand for biopharmaceuticals, especially recombinant therapeutic proteins, is expected to be a major driver of this expansion.
0 kommentar(er)
